Managed Markets
Network

News

What We're Reading: Price Hikes for Older Drugs; FDA Shifts Resources; Opioids and Birth Defects
What We're Reading: Price Hikes for Older Drugs; FDA Shifts Resources; Opioids and Birth Defects
January 18, 2019
Detection of Minimal Residual Disease Predicts Outcomes, Can Guide Strategies in AML
January 17, 2019 – Laura Joszt
Rural Patients More Likely to be Prescribed Opioids, CDC Says
January 17, 2019 – Allison Inserro
Earlier Treatment With Disease-Modifying Therapies Decreases Risk of MS Progression
January 17, 2019 – Laura Joszt
More >>>

Journals

The Health Information Technology Special Issue: New Real-World Evidence and Practical Lessons
The American Journal of Managed Care > January 2019
Mary E. Reed, DrPH
Cost of Care
Evidence-Based Oncology > January 2019
Clinical: Lymphoma
Evidence-Based Oncology > January 2019
Clinical: Myelofibrosis
Evidence-Based Oncology > January 2019
Inpatient Electronic Health Record Maintenance From 2010 to 2015
The American Journal of Managed Care > January 2019
Vincent X. Liu, MD, MS; Nimah Haq, MPH; Ignatius C. Chan, MD; and Brian Hoberman, MD, MBA
Clinical: Chronic Lymphocytic Leukemia
Evidence-Based Oncology > January 2019
Clinical: Multiple Myeloma
Evidence-Based Oncology > January 2019
Clinical: CAR T-Cell Therapy
Evidence-Based Oncology > January 2019
The Gamification of Healthcare: Emergence of the Digital Practitioner?
The American Journal of Managed Care > January 2019
Eli G. Phillips Jr, PharmD, JD; Chadi Nabhan, MD, MBA; and Bruce A. Feinberg, DO
More >>>

Conferences

Dr Robert Rifkin Discusses Barriers, Biomarkers in Multiple Myeloma
January 10, 2019 –
Dr Jennifer Brown on the Role of Genomic Sequencing in CLL
January 08, 2019 –
Dr Theresa Keegan on Barriers, Facilitators to Clinical Trial Participation Among AYAs
January 07, 2019 –
Dr Jeff Sharman: Cost of Therapy Is a Major Challenge in CLL
January 06, 2019 –
Dan Mendelson on the Shift to Value-Based Care and Prescribing Patterns
December 22, 2018 –
Dr Michael Thase: Patient Characteristics, Biomarkers That Guide Treatment for MDD
December 21, 2018 –
NCI Director Highlights a Year of Progress in Hematology, Outlines Areas of Focus Going Forward
December 18, 2018 – Jaime Rosenberg
Dr W. Clay Jackson Discusses Identifying, Addressing Clinician Burnout
December 18, 2018 –
Dr Michael Thase Outlines Developments in the Pathophysiology of Major Depressive Disorder
December 05, 2018 –
Dr Thorvardur Halfdanarson Discusses Lack of Risk Factors, Biomarkers in NETs
December 04, 2018 –
Dr Robert Rifkin Outlines Recent Treatment Advances in Multiple Myeloma
December 03, 2018 –
More >>>

Videos

Interviews

More >>>
Dr Barbara McAneny on Crafting New APMs and Improving Partnerships Between Physicians and Payers

Insights

More >>>
Treating Axial Spondyloarthritis

Peer Exchange

More >>>
Optimal Treatment of Schizophrenia: Take-Home Messages

Conference Perspectives

More >>>
Reimbursement With Treatment for Multiple Myeloma
ACCOUNTABLE CARE DELIVERY CONGRESS
CONTINUING EDUCATION
CONTRIBUTORS
MEETINGS
PARTICIPATE
COMPENDIA
In Focus Blog
Press Releases
Interactive Tools
Managed Care Podcast
Panel Discussions
Week In Review
Information for Reviewers
Information for Authors
Formulary Central
Clinical Study Summaries
Study Summaries
About Us
AJAC
AJMC
EBDM
EBO
AJMC Resources
Careers
Contact Us
Privacy Policy
Terms & Conditions
Subscribe
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
×

Sign In

Not a member? Sign up now!